Soluble LR11 Immunoassay Using Sulfobetaine Surfactants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for immunologically assaying soluble LR11 in biological samples are cumbersome and impractical for clinical applications due to interference from unidentified substances, requiring extended reaction times and affecting measurement correlation.

Innovation Solution

Treatment of biological samples with sulfobetaine amphoteric or amidosulfobetaine amphoteric surfactants allows for shorter primary reaction times without compromising measurement accuracy, enabling efficient and sensitive quantitation of soluble LR11 levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional immunological assay methods are used to determine soluble LR11, then measurement accuracy is maintained, but assay time is excessively long and interfering substances affect results

Engineering Contradiction:
Improvemeasurement accuracyVSAvoidassay time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent changes the chemical parameters of the assay system by introducing specific surfactants (Tween 20, Triton X-100, CHAPS, or N-acyl-N-methylglucamine) at optimized concentrations. These parameter changes modify the interaction between interfering substances and the antibody-antigen complex, allowing the assay to proceed rapidly (1 hour or less) while maintaining accuracy by eliminating interference effects.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If primary reaction time is shortened to increase productivity, then assay speed improves, but measurement correlation deteriorates

Engineering Contradiction:
Improveassay speedVSAvoidmeasurement correlation
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent introduces surfactants as intermediary substances that mediate the interaction between soluble LR11 and anti-LR11 antibodies. These intermediaries create a favorable microenvironment that accelerates the primary reaction kinetics while maintaining the specificity and correlation of measurements, enabling short reaction times without sacrificing measurement quality.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If simple immunological assay methods are used, then ease of operation improves, but interfering substances in biological samples cause incorrect determination

Engineering Contradiction:
Improvesimplicity of methodVSAvoiddetermination accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent modifies the assay parameters by incorporating surfactants into the assay buffer system. This parameter change maintains the simplicity of the immunological assay format while fundamentally improving accuracy by eliminating interference from biological sample components through the surfactant's ability to solubilize and neutralize interfering substances.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method significantly reduces assay time to one hour while maintaining the correlation and sensitivity of measurements, effectively eliminating the interference from substances present in the samples.

Implementation Method 1

the method comprises treating the sample with one or more surfactants selected from one or more sulfobetaine amphoteric surfactants and one or more amidosulfobetaine amphoteric surfactants

Methodology Applied
Scientific EffectSurfactant: Surfactant

Implementation Method 2

employing an anti-soluble LR11 antibody... reaction between immobilized anti-soluble LR11 antibodies and soluble LR11

Methodology Applied
Scientific EffectAntigen-antibody binding:

Data Source

PatentEP2708893B1Method for immunologically measuring soluble LR11
Publication Date: 2017.04.19 SEKISUI MEDICAL CO LTD
  • EP2708893B1 patent drawingFigure 1
  • EP2708893B1 patent drawingFigure 2
  • EP2708893B1 patent drawingFigure 3

AI summary

To provide a method for assaying soluble LR11 in a biological sample, which method realizes a simple and accurate assay of soluble LR11 present in the sample by immunological means without requiring isolation of soluble LR11 from the biological sample (e.g., a serum sample). The method of the invention for immunologically assaying soluble LR11 present in a biological sample, characterized in that the method includes treating the sample with at least one surfactant selected from among one or more sulfobetaine amphoteric surfactants and one or more amidosulfobetaine amphoteric surfactants.